000 | 04633cam a2200673Ia 4500 | ||
---|---|---|---|
001 | ocn694733434 | ||
003 | OCoLC | ||
005 | 20171023122232.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 110103s2011 nyua ob 001 0 eng d | ||
020 |
_a9781441972163 _q(electronic bk.) |
||
020 |
_a1441972161 _q(electronic bk.) |
||
020 |
_a9781441972156 _q(electronic bk.) |
||
020 |
_a1441972153 _q(electronic bk.) |
||
029 | 1 |
_aAU@ _b000048771752 |
|
029 | 1 |
_aAU@ _b000049595547 |
|
029 | 1 |
_aDEBSZ _b430928793 |
|
029 | 1 |
_aGBVCP _b790038005 |
|
029 | 1 |
_aNZ1 _b13777845 |
|
029 | 1 |
_aNZ1 _b15921957 |
|
029 | 1 |
_aDEBBG _bBV043392620 |
|
035 |
_a(OCoLC)694733434 _z(OCoLC)698589443 _z(OCoLC)748435289 _z(OCoLC)771448200 _z(OCoLC)798698956 |
||
037 |
_a978-1-4419-7215-6 _bSpringer _nhttp://www.springerlink.com |
||
040 |
_aGW5XE _beng _epn _cGW5XE _dEBLCP _dOCLCQ _dMHW _dOCLCQ _dOCLCF _dOCLCQ _dE7B _dN$T _dRRP _dOCLCO _dYDXCP _dDEBSZ _dOCLCO _dDG1 _dOCLCO _dOCLCQ _dOCLCO _dOCLCQ _dDEBBG _dDG1 |
||
049 | _aMAIN | ||
050 | 4 |
_aRC280.O8 _bE44 2011 |
|
060 | 4 | _a2011 B-194 | |
060 | 4 | _aWP 322 | |
066 | _c(S | ||
072 | 7 |
_aHEA _x039030 _2bisacsh |
|
072 | 7 |
_aMED _x062000 _2bisacsh |
|
082 | 0 | 4 |
_a616.99/465 _222 |
245 | 0 | 0 |
_aEmerging therapeutic targets in ovarian cancer / _cStan Kaye [and others], editors. _h[electronic resource] |
260 |
_aNew York : _bSpringer Science+Business Media, LLC, _c©2011. |
||
300 |
_a1 online resource (xiii, 291 pages) : _billustrations |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aPreface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer. | |
520 | _aThis book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers. | ||
588 | 0 | _aPrint version record. | |
650 | 0 |
_aOvaries _xCancer _xTreatment. |
|
650 | 1 | 2 |
_aOvarian Neoplasms _xtherapy. |
650 | 2 | 2 |
_aAntineoplastic Agents _xtherapeutic use. |
650 | 2 | 2 | _aDrug Design. |
650 | 2 | 2 |
_aDrug Therapy _xtrends. |
650 | 4 | _aMedicine. | |
650 | 7 |
_aHEALTH & FITNESS _xDiseases _xCancer. _2bisacsh |
|
650 | 7 |
_aMEDICAL _xOncology. _2bisacsh |
|
650 | 7 |
_aOvaries _xCancer _xTreatment. _2fast _0(OCoLC)fst01049287 |
|
655 | 4 | _aElectronic books. | |
700 | 1 | _aKaye, Stanley B. | |
776 | 0 | 8 |
_iPrint version: _tEmerging therapeutic targets in ovarian cancer. _dNew York : Springer, ©2011 _z9781441972156 _w(OCoLC)702604723 |
856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118185537 _zWiley Online Library |
880 | 0 |
_6505-00/(S _aSystemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs / Susana Banerjee, Michael A. Bookman, and Martin Gore -- Discovery of Novel Targets / John Farley and Michael J. Birrer -- Novel Anti-angiogenic Therapies in Ovarian Cancer / Jurjees Hasan and Gordon Jayson -- Targeting the AKT Pathway in Ovarian Cancer / Euan A. Stronach [and others] -- Inhibition of the Src Oncogene : Therapeutic Potential in Ovarian Carcinoma / Liz Y. Han and Anil K. Sood -- Tumour-Specific Synthetic Lethality : Targeting BRCA Dysfunction in Ovarian Cancer / Timothy A. Yap [and others] -- Targeting Inflammatory Pathways in Epithelial Ovarian Cancer / Jermaine Coward and Frances Balkwill -- Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer : Moving Forward in the Era of Molecularly Targeted Therapy / Lainie P. Martin, Julia J. Perkins, and Russell J. Schilder -- Epigenetic Therapies / Robert Brown, Nadine Chapman-Rothe, and Ros Glasspool -- Ovarian Cancer Immunology and Immunotherapy / Sadaf Ghaem-Maghami and Martin Gore -- Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential / Susan K. Murphy and Andrew Berchuck -- Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer / Chau H.M. Ng and Ann L. Jackman -- New Insights into Tubulin Binders / Carles Escriu and James D. Brenton. |
|
942 |
_2ddc _cBK |
||
999 |
_c208322 _d208322 |